Blacksmith Medicines Co-Founder Presents At The 21St International Conference On Biological Inorganic Chemistry
01 Aug 2025 17:10 GMT
(MENAFN- PR Newswire)
Presentation highlights Blacksmith's novel chemistry platform for targeting metalloenzymes and FG-2101, a first-in-class non-hydroxamate LpxC inhibitor
SAN DIEGO, Aug. 1, 2025 /PRNewswire/ -- Blacksmith Medicines, Inc. ( …
Biomea Fusion Reports Second Quarter 2025 Financial Results and Corporate Highlights
05 Aug 2025 20:05 GMT
… clinical-stage diabetes and obesity medicines company focused on the development of …
Gates Foundation pledges $2.5 billion to women’s health initiatives
04 Aug 2025 18:02 GMT
… cholesterol drug Leqvio at The Medicines Company, said that the foundation’s …
Biomea Fusion to Become a Diabetes & Obesity Medicines Company
13 Jan 2025 14:00 GMT
… become a diabetes and obesity medicines company. Based on the most recent …
Novartis twice-yearly* Leqvio® (inclisiran) receives FDA approval for new indication enabling first-line use
31 Jul 2025 21:11 GMT
… Novartis
Novartis is an innovative medicines company. Every day, we work to …
Inside the drugs factory: How captagon is fuelling the war in Sudan
28 Jul 2025 11:42 GMT
… the packets, Hi Pharm Veterinary Medicines Co, does not appear on Syria …